Which diseases do respiratory societies recommend the use of incentive spirometry, EzPAP, or Acapella, and should these devices be used in patients admitted to a skilled‑nursing facility who have no history of lung disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Respiratory Devices: Guideline Recommendations and Use in SNF Patients Without Lung Disease

Respiratory societies do not recommend routine use of incentive spirometry (IS), EzPAP, or Acapella devices in patients admitted to skilled nursing facilities who have no history of lung disease. These devices are indicated for specific respiratory conditions and postoperative settings, not for prophylactic use in patients without pulmonary pathology.

Diseases Where These Devices Are Recommended

Incentive Spirometry

IS alone is NOT recommended for routine postoperative pulmonary complication prevention 1. The 2011 AARC Clinical Practice Guideline explicitly states that IS should only be used in combination with deep breathing techniques, directed coughing, early mobilization, and optimal analgesia—not as a standalone intervention 1.

  • No benefit demonstrated for routine use after upper abdominal surgery or coronary artery bypass graft surgery 1
  • Recent meta-analysis confirms IS alone does not reduce 30-day postoperative pulmonary complications, mortality, or hospital length of stay after cardiac, thoracic, or upper abdominal surgery 2
  • Deep breathing exercises provide equivalent benefit without requiring a device 1

EzPAP (Positive Expiratory Pressure Devices)

EzPAP and similar PEP devices show limited evidence-based indications:

  • Bronchiectasis: Acapella (oscillating PEP device) has been studied but evidence is very low quality. One small study showed non-significant reduction in exacerbations, and the device was preferred by some patients for comfort 3, 4
  • Postoperative cardiac surgery: OPEP devices show superior outcomes compared to IS, with improved oxygenation, shorter ICU stays, and better 6-minute walk test results 5

Acapella (Oscillating PEP Device)

Recommended primarily for diseases with excessive mucus production:

  • Cystic fibrosis: Part of airway clearance regimen 6
  • Bronchiectasis: May be used as part of multimodal airway clearance therapy, though evidence quality is low 3, 4
  • Duchenne muscular dystrophy: Mechanical insufflation-exsufflation strongly supported; other oscillatory devices have limited evidence 7

NOT recommended after pulmonary lobectomy when added to standard multimodal physiotherapy—provides no additional benefit 8

Should These Devices Be Used in SNF Patients Without Lung Disease?

No. There is no evidence supporting prophylactic use of IS, EzPAP, or Acapella in patients without respiratory disease.

Key Reasoning:

  1. No preventive indication exists: Guidelines consistently show these devices are ineffective for preventing pulmonary complications in patients without underlying respiratory pathology 1, 2

  2. Resource misallocation: Using these devices in patients without lung disease diverts resources from patients who would actually benefit (those with COPD exacerbations, bronchiectasis, neuromuscular disease, or specific postoperative conditions)

  3. False sense of security: Routine device use may substitute for interventions that actually prevent complications—early mobilization, adequate pain control, and deep breathing exercises 1

When Respiratory Support IS Indicated in SNF Settings:

Non-invasive ventilation (NIV/BiPAP) has clear indications 9:

  • COPD exacerbation with respiratory acidosis (pH <7.35) despite maximal medical therapy
  • Cardiogenic pulmonary edema with persistent hypoxia (CPAP first-line)
  • Acute-on-chronic hypercapnic respiratory failure from chest wall deformity or neuromuscular disease
  • Decompensated obstructive sleep apnea with respiratory acidosis

CPAP for specific acute conditions 10:

  • Postoperative hypoxemia in patients at high risk for acute respiratory failure
  • Must be delivered in monitored setting with staff trained in the technique

Common Pitfalls to Avoid:

  • Do not order IS "for atelectasis prevention" in patients without surgical history or underlying lung disease—it doesn't work 1
  • Do not use Acapella or PEP devices in patients without mucus hypersecretion—these are airway clearance devices, not lung expansion devices
  • Do not confuse NIV/BiPAP with simple airway clearance devices—NIV requires specific indications, monitoring, and trained staff 9
  • Avoid device-only approaches: If respiratory therapy is needed postoperatively, multimodal physiotherapy (early mobilization, breathing exercises, coughing techniques, pain management) is superior to any single device 8

Bottom Line for SNF Admissions:

For patients admitted to SNF without lung disease history: Focus on early mobilization, adequate nutrition, and monitoring for development of respiratory symptoms. Reserve respiratory devices for patients with documented respiratory conditions requiring airway clearance (bronchiectasis, CF) or those developing acute respiratory failure meeting specific NIV criteria. The evidence does not support prophylactic device use in this population.

References

1
Research

Incentive spirometry: 2011.

Respiratory care, 2011

7
Guideline

respiratory care of the patient with duchenne muscular dystrophy: ats consensus statement.

American Journal of Respiratory and Critical Care Medicine, 2004

Related Questions

Should incentive spirometry, ezPAP (expiratory positive airway pressure), or Acapella (vibratory airway clearance device) be used routinely for a general skilled nursing facility or long‑term care patient population who are breathing room air, have no history of pulmonary disease, and are only limited by reduced activity?
Is requiring incentive spirometry, EzPAP (positive airway pressure device), and Acapella (airway clearance device) for all patients breathing room air without a history of respiratory disease medically justified, or could it constitute Medicare fraud?
Can an incentive spirometer be used for chest physiotherapy after thyroidectomy?
Can you provide a step‑by‑step explanation of how to read and interpret a spirometry report?
What are the contraindications for using an Acapella positive expiratory pressure (PEP) device in a chronically tracheostomized adult patient?
In a 32-year-old pregnant woman presenting with knee swelling suggestive of arthritis, what are the differential diagnoses?
In a 50-year-old man presenting with fever, persistent hiccups, mild anemia, neutrophilic leukocytosis, normal platelet count, mildly elevated creatinine, and positive C-reactive protein, what is the most likely diagnosis and appropriate treatment including dosages?
How do clozapine, aripiprazole, and cariprazine compare in terms of prescription frequency and extrapyramidal side effect risk?
Can a potassium chloride (KCl) intravenous solution containing 2 mEq per millilitre be added directly to a modified Ringer's (Ringer's lactate) solution?
Which psychotropic medications are most likely to cause hyponatremia, and how should they be monitored and managed, especially in elderly female patients with low body weight or on thiazide/loop diuretics?
What empiric anti‑pseudomonal therapy should be used for a gram‑negative, non‑lactose‑fermenting, oxidase‑positive organism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.